Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

No-Receipt date 2022-00810 - 02/03/2022
No-Filing date 20220400492 - 02/03/2022
No-Granting date 3109835 - 11/03/2022
No-EPO application date 18724754.9 - 30/04/2018
No-EPO granting date 3601283 - 29/12/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2022 - 18/04/2022
Expiration date 01/05/2038
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US201762492574 P01/05/2017/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/437
A61P 11/00
A61P 17/00
A61P 27/02
C07D 471/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1395769 THERAVANCE BIOPHARMA R&D IP, LLC 901 GATEWAY BOULEVARDSOUTH SAN FRANCISCO, CA 94080 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3593792 FATHEREE, PAUL R.
3593793 JIANG, LAN
3593794 MCKINNELL, ROBERT MURRAY
3593795 THALLADI, VENKAT R.
3593796 ZHANG, HAO
3593797 DABROS, MARTA
3593798 NZEREM, JERRY
3593799 BENJAMIN, NOAH
3593800 KLEINSCHEK, MELANIE A.
3593801 CRATER, GLENN D.

Representatives
CodeFirstnameSurnameAddressTownZip
3089NIKOLAOSLYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"STOURNARI 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
7915NIKOLAOSLYMPERISSTOURNARI 37ATHINA (ATTIKIS)10682 GREECE

Owners History

Title Instruments
DateOperationDescreption
11/4/2024 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 10/2024 Αρ. Πρωτ. ΓΔ 3111/04.11.2024

Payments history 6 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).